1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AKEBIA THERAPEUTICS INC.
Akebia Therapeutics Inc.
XNAS: AKBA
1.40 0.02 (1.45%)
2.6M
XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Akebia Therapeutics Inc is on 08 May 2026 for the purpose of Akebia Therapeutics Inc First Quarter Earnings Results for 2026 See details

Akebia Therapeutics Inc - AKBA - stock price prediction, stock price target, analyst ratings from 5 analysts

Akebia Therapeutics Inc has a share price target of US$ 4, revenue growth forecast of -5.8%, and profit growth estimate of -190.1% for FY26, based on top 5 analyst calls.